BIOLOGIC AGENTS IN IBD PATIENTS AFTER SOLID ORGAN TRANSPLANTATION DO NOT INCREASE THE RATES OF INFECTION OR ADVERSE EVENTS
Linda Cingolani 1
Greta Lorenzon 1
Fabiana Zingone 1
Renata D'Incà 1
Ilaria Marsilio 1
Brigida Barberio 1
Flavio Caprioli 2
Davide Giuseppe Ribaldone 3
Antonio Rispo 4
Agnese Miranda 5
Daniela Pugliese 6
Lorenzo Bertani 7
Ambrogio Orlando 8
Andrea Buda 9
Alberto Ferrarese 10
ANTONINO CARLO Privitera 11
Martina Gambato 11
Patrizia Burra 11
Edoardo Vincenzo Savarino 11
1 Padua University Hospital, Padua, Italy
2 Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico of Milan, Milan, Italy
3 University of Turin, Turin, Italy
4 University ´´Federico II´´of Naples, Naples, Italy
5 University of Naples ''Luigi Vanvitelli'', Dragoni ( Caserta), Italy
6 Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
7 University of Pisa, Pisa, Italy
8 Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
9 Ospedale S. Maria del Prato, Feltre, Italy
10 Verona University Hospital, Verona, Italy
11 “Cannizzaro" Hospital of Catania, Catania, Italy
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]